메뉴 건너뛰기




Volumn 72, Issue 22, 2009, Pages 1884-1885

NSAID exposure and risk of Alzheimer disease: Is timing everything?

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

EID: 67650066956     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181a81664     Document Type: Editorial
Times cited : (4)

References (10)
  • 1
    • 0035936004 scopus 로고    scopus 로고
    • Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease
    • in t' Veld BA, Ruitenberg A, Hofman A, et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 2001;345:1515-1521.
    • (2001) N Engl J Med , vol.345 , pp. 1515-1521
    • in t'1    Veld, B.A.2    Ruitenberg, A.3    Hofman, A.4
  • 2
    • 44949084672 scopus 로고    scopus 로고
    • Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology
    • Arvanitakis Z, Grodstein F, Bienias JL, et al. Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology. Neurology 2008;70:2219-2225.
    • (2008) Neurology , vol.70 , pp. 2219-2225
    • Arvanitakis, Z.1    Grodstein, F.2    Bienias, J.L.3
  • 3
    • 34249058674 scopus 로고    scopus 로고
    • Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial
    • ADAPT Research Group
    • ADAPT Research Group. Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology 2007;68:1800-1808.
    • (2007) Neurology , vol.68 , pp. 1800-1808
  • 4
    • 47549107705 scopus 로고    scopus 로고
    • Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): Results of a randomized, controlled trial of naproxen and celecoxib
    • ADAPT Research Group
    • ADAPT Research Group. Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib. Arch Neurol 2008;65:896-905.
    • (2008) Arch Neurol , vol.65 , pp. 896-905
  • 5
    • 66649131390 scopus 로고    scopus 로고
    • Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort
    • Breitner JCS, Haneuse SJPA, Walker R, et al. Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort. Neurology 2009;72: 1899-1905.
    • (2009) Neurology , vol.72 , pp. 1899-1905
    • Breitner, J.C.S.1    Haneuse, S.J.P.A.2    Walker, R.3
  • 6
    • 20544462061 scopus 로고    scopus 로고
    • Obesity in middle age and future risk of dementia: A 27 year longitudinal population based study
    • Whitmer RA, Gunderson EP, Barrett-Connor E, Quesen- berry CP Jr, Yaffe K. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 2005;330:1360.
    • (2005) BMJ , vol.330 , pp. 1360
    • Whitmer, R.A.1    Gunderson, E.P.2    Barrett-Connor, E.3    Quesen- berry Jr, C.P.4    Yaffe, K.5
  • 7
    • 25444473999 scopus 로고    scopus 로고
    • Buchman AS, Wilson RS, Bienias JL, Shah RC, Evans DA, Bennett DA. Change in body mass index and risk of incident Alzheimer disease. Neurology 2005;65:892-897.
    • Buchman AS, Wilson RS, Bienias JL, Shah RC, Evans DA, Bennett DA. Change in body mass index and risk of incident Alzheimer disease. Neurology 2005;65:892-897.
  • 8
    • 84942481063 scopus 로고    scopus 로고
    • Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R. Influence of education and occupation on the incidence of Alzheimer's disease Jama 1994;271-:1004
    • Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R. Influence of education and occupation on the incidence of Alzheimer's disease Jama 1994;271-:1004
  • 10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.